Theravance Biopharma

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TBPH and other ETFs, options, and stocks.

About TBPH

Theravance Biopharma, Inc. is a biopharmaceutical company, which engages in the discovery, research, development, and commercialization of respiratory medicines. It operates through the U.S. and Europe geographical segments.

CEO

Rick E. Winningham

CEORick E. Winningham

Employees

Employees97

Headquarters

South San, California

HeadquartersSouth San, California

Founded

2013

Founded2013

Employees

Employees97

TBPH Key Statistics

Market cap

693.98M

Market cap693.98M

Price-Earnings ratio

59.47

Price-Earnings ratio59.47

Dividend yield

—

Dividend yield—

Average volume

592.21K

Average volume592.21K

High today

$14.27

High today$14.27

Low today

$13.60

Low today$13.60

Open price

$14.05

Open price$14.05

Volume

608.06K

Volume608.06K

52 Week high

$14.30

52 Week high$14.30

52 Week low

$7.88

52 Week low$7.88

TBPH News

TipRanks 10h

Theravance Completes Enrollment in Phase 3 CYPRESS Study

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

TipRanks 10h

Theravance Biopharma completes enrollment in CYPRESS study

Theravance Biopharma (TBPH) announced completion of enrollment in the open-label portion of its pivotal Phase 3 CYPRESS study in patients with symptomatic neuro...

People also own

Based on the portfolios of people who own TBPH. This list is generated using Robinhood data, and it’s not a recommendation.